Physician profile
Rashmi Arora
NPI 1386712800
$319.86
in general payments reported to CMS, 2019-2025
7 companies · $38.69 in 2025
The $38.69 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.08 · 2020: $13.76 · 2021: $47.80 · 2022: $18.49 · 2023: $30.91 · 2024: $129 · 2025: $38.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $92.68 · Education: $90.00 · Long Term Medical Supply Or Device Loan: $16.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $92.68 |
| Education | $90.00 |
| Long Term Medical Supply Or Device Loan | $16.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $90.00 | 2024 | |
| Glaxosmithkline, LLC. | $71.33 | 2019-2025 | Penmenvy, Bexsero |
| Merck Sharp & Dohme LLC | $60.80 | 2021-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Sanofi Pasteur INC. | $42.16 | 2019-2022 | |
| Kyowa Kirin, INC. | $23.49 | 2025 | |
| Baxter Healthcare | $16.05 | 2024 | Hillrom - Spot Vision Screener |
| Cranial Technologies, INC | $16.03 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rashmi Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.